FT US Healthcare and Life Sciences

Thank You And See You Next Year

We would like to thank all the organizations, our sponsors, Exhibitors, visitors and all the supporting staff for making our event an overhelming success with space currently reserved for next year
Write a Review
Visitors: 175 

Following the success of last year's US Healthcare and Life Sciences Conference, the Financial Times, in association with Deloitte, hosted the second annual conference at the Metropolitan Club in New York on June 6, 2013.

The conference built on some of last year's themes and also focused on the practicalities of dealing with the provisions and impacts of US healthcare reform-taking its core theme as "Transformation Beyond Healthcare Reform". There is real appetite to know what the establishment of new institutions such as Accountable Care Organisations (ACOs) will mean for the future prospects for life science companies - are they a threat or an opportunity - and how changes in the payer/healthcare industry landscape, and their growing emphasis on the value they provide rather than products, might impact the industry's future profitability.

The conference also focused on other topical themes such as:

New models for financing R&D
Opportunities in emerging markets beyond the BRIC countries as the next range of countries start to attract the attention of life science companies
Challenges and opportunities represented by the increasing convergence between pharmacy diagnostic and devices companies and products

The FT US Healthcare and Life Sciences Conference brought together a distinguished line-up of industry experts, government decision-makers and leading market commentators to review the shifting sands of the US healthcare industry, and explore direct and indirect implications of reform for key stakeholders-payers, life science companies, healthcare providers, investors and patients.
This event is for CEOs, CFOs, CIOs, Chief Medical Officers, Chief Strategy Officers, Heads of R&D, Emerging Markets, Consumer Health, Government Relations, Pricing, Regulation, etc. and other senior-level executives in the following sectors:

Pharmaceuticals, Biotechnology, Generic and Specialty Pharmaceutical companies
Medical Devices and Diagnostics
Investment (Fund Managers, Venture Capitalists, Private Equity firms, Investment Bankers, IP Groups)
Legal Counsel
Healthcare IT (Patient records, data, mobile healthcare applications, social media)

For more information about this conference, please contact Chrissy McNasby at or +1 917-551-5101.


Chrissy McNasby
+1 917-551-5101

Tim Powell
+1 917-551-5097


Angela Letivov
Add Your Review

No reviews were posted
Share your updates and messages to subscribers here. By configuring all your social networks to Trade Show Connection, followers, friends, and connections will automatically be updated from this network.